Blepharoplasty in Curitiba Brazil
Blepharoplasty in Curitiba section, includes general infrmation about Blepharoplasty Procedure, Blepharoplasty Curitiba Local News, Blepharoplasty Curitiba Surgeon Locator and other Blepharoplasty related material.
Blepharoplasty Procedure
This cosmetic surgical procedure intends to reshape the upper eyelid or lower eyelid by the removal and/or repositioning of excess tissue. The procedure also reinforces the surrounding muscles and tendons.
Medical needs
When an advanced amount of upper eyelid skin is present, the skin may hang over the eyelashes and cause of loss of peripheral vision. The outer and upper parts of the visual field are most commonly affected. Such condition may result in difficulty with activities such as driving or reading.
Cosmetic needs
Patients with a less severe amount of excess skin may still wish to undergo similar procedure for cosmetic reasons. Lower eyelid blepharoplasty is almost always done for cosmetic reasons, to improve puffy lower eyelid "bags" and reduce the wrinkling of skin.
The procedure
Blepharoplasty is performed through external incisions made along the natural skin lines of the eyelids. Such location may be the creases of the upper lids and below the lashes of the lower lids, or from the inside surface of the lower eyelid.
Duration
The operation takes one to three hours to complete, depending on the scope of the procedure. Initial swelling and bruising take one to two weeks to resolve. However, until the final result becomes stable, it needs at least several months to heal.
The outcome
The cosmetic outcome of the procedure depends on the anatomy of the upper/lower eyelids, the patients' skin quality, the patients' age, and the bony tissues and soft tissues which are adjacent to the location the Blepharoplasty took place.
Complications
There are factors known to cause complications after surgery. Failure to recognize such factors before the operation may result in undesired outcome. For example, such factors may be:
• Pre-existing dry eyes. The situation after operation may become worse, by disrupting the natural tear film;
• Laxity (looseness) of the lower lid margin (edge), which caused lower lid malposition;
• Prominence of the eye in relation to the malar (cheek) complex, which causes lower lid malposition.
Average costs
Average physician/surgeon fee for blepharoplasty (aesthetic plastic surgery) in 2005 was around $3,000. These fees are for the physician/surgeon fees only and do not include fees for the surgical facility, anesthesia, medical tests, prescriptions, surgical garments or any other costs related to the surgery. Physicians most qualified to perform blepharoplasty are plastic surgeons, otolaryngologies, ophthalmologists, and those that practice oral and maxillofacial surgery.
Asian blepharoplasty
An upper blepharoplasty in someone who is Asian is termed Asian blepharoplasty or double eyelid surgery. It is the most popular form of cosmetic surgery among those of East and Southeast Asian background. Due to anatomic differences between the Asian and occidental eyelid, about half of this population are born without a supratarsal eyelid crease and are called single-lidded. Surgery can be used to artificially create a crease above the eye.
Transconjunctival blepharoplasty
Transconjunctival blepharoplasty involves removing lower eyelid fat through an incision on the back of the eyelid, eliminating the need for an external incision. Since there is no external incision, excess skin can not be removed during the surgery, but skin resurfacing with a chemical peel or carbon dioxide laser may be performed simultaneously. This allows for a faster recovery process.
Other Blepharoplasty Procedures
All Face Procedures
Blepharoplasty curitiba (current)
curitiba BOTOX® Cosmetic
curitiba Ear Surgery
curitiba Facelift
curitiba Browlift
More Curitiba info...
Curitiba By train
Due to brazilian government decision on not providing passenger train services anymore, Curitiba is no longer serviced by scheduled passenger train sevice. However, there is a touristic train route that goes to Paran? State's ocean coast, reaching its end in Paranagu?. It is definitely a worth ride for those willing to see natural and Atlantic Forrest scened, with lots of waterfalls, cliffs, peaks and historic sites.
-
Curitiba Splurge
Durski - Slavic cuisine (Ukranian, Polish and Russian) in the Old Town
Grimpa Steakhouse
Saanga Grill
Le Rechaud is a very good swiss restaurant recomended for couples, with a very reserved atmosphere. -
Plastic Surgery News...
- Three-year results reported from a controlled trial of etanercept plus methotrexate (MTX) in patients with rheumatoid arthritis (RA) confirm the continued efficacy of the combination against monotherapy, with no unexpected adverse effects.
The TEMPO trial was planned from outset as a longer-term, three-year study. It compared etanercept plus MTX against either drug as monotherapy in adult patients with active RA not responding to at least one previous DMARD other than MTX. They were randomised to double-blind treatment with etanercept, MTX, or the combination; initial outcomes focussed on response to treatment using ACR criteria. For the long-term phase, the outcomes used were disease activity and remission using the Disease Activity Score (DAS); response according the ACR score was also assessed. The authors used statistical techniques that attempted to correct for biases inherent in long-term therapeutic trials.
TEMPO initially randomised 686 patients, of whom 682 received at least one dose of study drug. Over the three years, 350 patients withdrew from the trial, with more withdrawals due to inefficacy in the monotherapy groups (combination group 5% vs. 16% for etanercept and 17% for MTX). Analysis indicated that those in the combination therapy group had greater improvement in DAS and were more likely to remain in remission than those in either monotherapy group. Patients in the combination group did better than those in the monotherapy groups on most other outcomes; the combination and etanercept were both better than MTX alone for radiographic progression. Adverse effects were similar across the three groups, and no new or unexpected adverse effects were reported in year three.
Overall, the authors conclude that etanercept plus MTX combination treatment continued to show superior efficacy to monotherapy over three years, even after adjustment for withdrawals. There were no additional safety concerns.
- The National Institute for Mental Health in England (NIMHE) in association with the Department of Health has published a “leaflet” aiming to encourage service users and carers to ask relevant questions about medication and have their views taken into account. Additionally, the publication aims to help health and social care practitioners improve their person-centred approach in the area of medicines management.